Answers are grounded in this paper and cite their sources.
In a cohort of older adults with advanced cancer, polypharmacy and PDIs were associated with an increased risk of adverse treatment outcomes. Providing meaningful screening and interventional tools to optimize medication use may improve treatment-related outcomes in these patients.
No takes yet. Share an insight, caveat, or question.
Mohamed et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: